The North America Cell Viability Assays Market would witness market growth of 8.5% CAGR during the forecast period (2022-2028).
It is recommended to understand the quantity of the remaining viable cells after the experiment, regardless of the type of cell-based assay employed. Various assay methods can determine the number of viable eukaryotic cells. Some of them are resazurin reduction, protease markers, ATP detection, and tetrazolium reduction.
The tetrazolium reduction, protease activity assays, and resazurin reduction assays measure some aspect of the enzymatic activity or general metabolism as a viable cells’ marker. To transform a substrate into a fluorescent or colored product that is detectable with the help of a plate reader, all of these assays require incubating a reagent with the viable cell population. A signal in proportion to the quantity of the present viable cells will be created when the substrates are set with the viable cells under most standard cultural conditions.
Most of the medical decisions rely on laboratory test results, which showcase the crucial role of clinical laboratories in the present healthcare system. According to Center of Centers for Disease Control and Preventions, annually, approximately 14 billion laboratory tests are ordered, and for an effective diagnosis and treatment of disease, quality, cost-effectiveness, and safe laboratory testing are required.
The US market dominated the North America Cell Viability Assays Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $634.6 million by 2028. The Canada market is poised to grow at a CAGR of 10.9% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 9.9% during (2022 - 2028).
Based on Product, the market is segmented into Consumables (Reagents & Assay Kits and Microplates) and Instruments (Spectrophotometer, Microscopy, Cell Imaging & Analysis System, Flow Cytometry, and Others). Based on Reagents & Assay Kits, the market is segmented into Luminometric Assays, Dye Exclusion Assays, Colorimetric Assays, and Fluorometric Assays. Based on End User, the market is segmented into Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, Academic & Research Institutes, and Diagnostic Labs. Based on Application, the market is segmented into Stem Cell Research, Drug Discovery & Development, and Diagnostics. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Cell Viability Assays Market is Predict to reach $2.5 Billion by 2028, at a CAGR of 9.7%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Bio-Rad Laboratories Inc., Merck KGaA, Becton, Dickinson and Company, PerkinElmer Inc., Promega Corporation, Biotium, Creative Bioarray, and Abcam Plc.
By Product
By End User
By Application
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 